Pharmacy
4 articles in this category
A dialysis drug softens the shield around pancreatic cancer in patients’ biopsies
Pancreatic tumours surround themselves with dense tissue that shields them from drugs and immune cells. In a small trial, an old drug for kidney patients weakened this shield and let more immune cells into the tumour.
Teflon waste turned into a drug building block
A Hokkaido team turns fluoroform — a cheap greenhouse gas from Teflon plants — into a CF₃ radical under purple light. For drug chemistry it is a duel between catalog reagents and industrial waste.
Cell therapy in a drip. No weeks in a factory
Cell therapy may enter a vein like an ordinary drip, without weeks in a cell factory. Early results from 16 patients point to a cheaper path than today’s treatments worth over a million zlotys.
A few atoms decide whether a drug reaches the lungs or the liver. The linker paradox in nanomedicine
Two nearly identical nanoparticles land in the same organs. One delivers mRNA to the lungs, the other sinks into the liver. Dan Peer's team at Tel Aviv University discovered that what decides this is a few atoms in the lipid linker, the part of the molecule everyone had overlooked.